Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer
- 25 March 2005
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 56 (1) , 22-28
Abstract
We speculated whether or not the expression level of telomerase reverse transcriptase (hTERT) would be modulated by agents targeting epigenetics in oral cancer cell lines. Although hTERT is known to be targeted by epigenetic changes, it remains unclear how chemoagents targeting epigenetics work on hTERT transcription. In the present study, the epigenetic effects of the histone deacetylase (HDAC) inhibitor FR901228 on hTERT transcription in oral cancer cell lines were analyzed by RT-PCR. The mRNA expression of hTERT was upregulated after exposure to FR901228 in hTERT-negative Hep2 cells, and even SAS and KB cells expressed high levels of hTERT. Moreover, cotreatment of protein synthesis inhibitor cycloheximide (CHX) resulted in the induction of hTERT transcription by FR901228. This suggests that the induction of hTERT by FR901228 requires de novo protein synthesis to some extent and is more likely a direct than an indirect effect on epigenetic changes such as histone acetylation/deacetylation. We further examined the effect of FR901228 on c-myc protein, which is one of the main hTERT transcription activators. FR901228 repressed c-myc protein only in the absence of CHX, and depended on the enhancement of de novo protein synthesis. Our results indicate that c-myc protein is repressed indirectly by FR901228 but may not contribute to FR901228-induced hTERT transcription. The present study showed that the HDAC inhibitor FR901228 induced the hTERT gene by a complex mechanism that involved transcription factors other than c-myc, in addition to inhibition of histone deacetylation.Keywords
This publication has 26 references indexed in Scilit:
- Effects of demethylating agent 5-aza-2′-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell linesOral Oncology, 2004
- Evidence for a Relief of Repression Mechanism for Activation of the Human Telomerase Reverse Transcriptase PromoterJournal of Biological Chemistry, 2003
- A Novel Tricomplex of BRCA1, Nmi, and c-Myc Inhibits c-Myc-induced Human Telomerase Reverse Transcriptase Gene (hTERT) Promoter Activity in Breast CancerJournal of Biological Chemistry, 2002
- THE MANY ROLES OF c-Myc IN APOPTOSISAnnual Review of Physiology, 1998
- Myc activates telomeraseGenes & Development, 1998
- Telomerase Catalytic Subunit Homologs from Fission Yeast and HumanScience, 1997
- Telomerase activation by the E6 gene product of human papillomavirus type 16Nature, 1996
- Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesisNature Genetics, 1996
- Sodium butyrate inhibits c-myc splicing and interferes with signal transduction in ovarian carcinoma cellsCarcinogenesis, 1995
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994